Radionuclide Therapy of HER2-Expressing Xenografts Using [(177)Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab

SIMPLE SUMMARY: Affibody molecules are artificial proteins that can recognize cancer-related molecular abnormalities in the living body. Clinical studies demonstrated that Affibody molecules can be successfully used for radionuclide diagnostics. Targeted radionuclide therapy selectively delivers cyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yongsheng, Xu, Tianqi, Vorobyeva, Anzhelika, Loftenius, Annika, Bodenko, Vitalina, Orlova, Anna, Frejd, Fredrik Y., Tolmachev, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177614/
https://www.ncbi.nlm.nih.gov/pubmed/37173878
http://dx.doi.org/10.3390/cancers15092409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177614/
https://www.ncbi.nlm.nih.gov/pubmed/37173878
http://dx.doi.org/10.3390/cancers15092409

Ejemplares similares